Health

Benefits of Bayesian Dose Escalation Designs for Oncology Studies, Upcoming Webinar Hosted by Xtalks

Leave a comment


These flexible methods may be more appropriate than those initially designed for chemotherapy drug development.


TORONTO (PRWEB)

As acceptance of flexible trial designs continues to advance, many sponsors are increasingly exploring alternate methods of dose escalation to support identification of a maximum tolerated dose (MTD) and recommended Phase II dose (RP2D) in open-label early phase or First-in-Human studies. Bayesian dose escalation designs have also coincided with advances in oncology therapy development, such as immunotherapies and antibody drug conjugates. These flexible methods may be more appropriate than those initially designed for chemotherapy drug development.

In this webinar, the featured speaker will discuss and cover: Common types of open-label adaptive dose escalation designs; Comparisons with rule-based designs; How to apply and use these designs in oncology therapy development; And how to determine which design is best suited for a clinical trial.

Register to learn the benefits of Bayesian dose escalation designs for oncology therapy development.

Join Vanessa Beddo, PhD, VP, Biostatistical Consulting, Allucent, for the live webinar on Monday, October 31, 2022, at 11am EDT (3pm GMT/UK).

For more information, or to register for this event, visit Benefits of Bayesian Dose Escalation Designs for Oncology Studies.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

Leave a Reply